24 Covid-19 studies now open at UCLH 

01/05/2020 00:00 
UCLH now has 24 active Covid-19 research studies – up from nine at the beginning of the month – with another 9 under consideration or being set up.
 

The 24 include trials of antiviral and immune modifying drugs, studies aiming to better understand the disease, and data initiatives analysing clinical information to improve treatment.

The Joint Research Office has set up a large number of studies while at the same time rapidly putting measures in place to pause existing studies. All other studies unless they involve treatment essential for serious of life-threatening conditions have been paused.

The UCLH Research Directorate’s Covid-19 Response Group continues to fast-track approvals and funding.

Last weekend, staff at the Joint Research Office succeeded in setting up a Covid-19 research study in just a matter of hours – a process that can be protracted because of how complex studies can be.

The COVACTA study, led by Dr Claire Roddie, is looking at whether tocilizumab developed by Roche can dampen the overactive immune response seen in some Covid-19 patients.

Dr Nick McNally, Managing Director of Research at UCLH, said: “I want to pay tribute to the commitment and dedication shown by the JRO since the outbreak of the pandemic. The dedication they have shown has been critical to all the research we have been able to do at this time.”

 Latest news

 Contact details

Communications unit
2nd floor central
250 Euston Road
London NW1 2PG

Media enquiries

Switchboard: 020 3456 7890
Media enquiries: 020 3447 7542 / 020 3447 9506
Email: uclh.media@nhs.net

Out of hours
The normal working hours for the Communications Unit are Monday to Friday 9am – 5pm. The only media enquiries that will be answered outside of these working hours are urgent enquiries and those relating to major incidents. To access the out-of-hours service call switchboard on 0845 155 5000.

Share this story